1445830-99-8Relevant academic research and scientific papers
SGC STIMULATORS
-
Page/Page column 155, (2016/04/10)
The present patent application discloses at least the compounds according to Formula I' shown below, or pharmaceutically acceptable salts thereof, Formula I' wherein ring D, ring A, ring E, ring F, JB, n, JD, J, o, RC1, R
SGC STIMULATORS
-
Paragraph 00287; 00288, (2016/04/20)
The present patent application discloses at least the compounds according to Formula I' shown below, or pharmaceutically acceptable salts thereof, Formula (I) wherein ring D, ring A, ring E, JB, n, JD, J, X, Z, Z1, RC
SGC STIMULATORS
-
Paragraph 00274, (2015/06/25)
The present patent application discloses at least the compounds according to Formula 1 shown below, or pharmaceutically acceptable salts thereof, wherein ringjB,n, JD, J,0, X, X1, J, R
HETEROARYL SUBSTITUTED PYRAZOLES
-
Page/Page column 129; 130, (2015/01/07)
Compounds of formula (I), which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
SUBSTITUTED BENZYLPYRAZOLES
-
Paragraph 0826 - 0829, (2014/10/29)
Compounds of formula (I) and their use as pharmaceutical.
SUBSTITUTED BENZYLPYRAZOLES
-
Page/Page column 114; 115, (2013/07/05)
Compounds of formula (I) and their use as pharmaceutical.
